Innovations

Convection-enhanced delivery of topotecan active in glioblastoma

0
Cloud computing banner background for smart city

A subcutaneously implanted, catheter-pump system capable of chronic convection-enhanced delivery (CED) of topotecan is well tolerated and active for patients with recurrent glioblastoma, according to a study published in the November issue of The Lancet Oncology.

Is the true story of ‘Cocaine Bear’ as wild as it sounds?

Previous article

National study suggests new vaccine is needed to prevent childhood pneumonia

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations